Supernus Pharmaceuticals Inc (SUPN)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -1 | 46,124 | 86,029 | 173,698 | 148,571 |
| Revenue | US$ in thousands | 607,521 | 673,056 | 560,079 | 500,962 | 392,755 |
| Operating profit margin | -0.00% | 6.85% | 15.36% | 34.67% | 37.83% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-1K ÷ $607,521K
= -0.00%
The operating profit margin of Supernus Pharmaceuticals Inc has exhibited a declining trend over the past five years. In 2019 and 2020, the company demonstrated robust operating efficiency with operating profit margins of 37.83% and 33.74% respectively. However, this trend reversed in the subsequent years, with the operating profit margin decreasing to 13.71% in 2021, 6.84% in 2022, and further declining to 2.21% in 2023.
The declining trend in operating profit margin suggests that Supernus Pharmaceuticals Inc may be facing challenges in maintaining profitability relative to its operating costs. It is important for the company to closely monitor and address the factors contributing to this decline to sustain and enhance its operational efficiency and overall financial performance in the future.
Peer comparison
Dec 31, 2023